Technology & Pipeline
We are currently developing our antibiotic product candidate, OG716 as well as other homolog antibiotic product candidates, and have other product candidates, including SMaRT Replacement Therapy positioned for outlicensing or partnering.
| Technology | Candidate | Indication | Development Stage | ||||
|---|---|---|---|---|---|---|---|
| Preclinical | Phase 1 | Phase 2 | Phase 3 | Market | |||
| Lantibiotics | OG716 | C.difficile |
Preclinical Phase in progress
|
Phase 1 Phase not started
|
Phase 2 Phase not started
|
Phase 3 Phase not started
|
Market Phase not started
|
Lantibiotics
Lantibiotics are a class of antibiotics with a novel mechanism of action active against several multi-drug resistant organisms.